A Comprehensive Approach for the Prevention of Nausea and Vomiting Following Sleeve Gastrectomy: a Randomized Controlled Trial.
Enhanced recovery
Nausea
PONV
Sleeve gastrectomy
Journal
Obesity surgery
ISSN: 1708-0428
Titre abrégé: Obes Surg
Pays: United States
ID NLM: 9106714
Informations de publication
Date de publication:
11 2020
11 2020
Historique:
received:
30
03
2020
accepted:
17
06
2020
revised:
15
06
2020
pubmed:
26
6
2020
medline:
15
4
2021
entrez:
26
6
2020
Statut:
ppublish
Résumé
Postoperative nausea and vomiting (PONV) following sleeve gastrectomy (SG) is a common occurrence. The effect of specific interventions in PONV prevention within enhanced recovery pathways remains unclear. The aim of this study was to evaluate the impact of a comprehensive approach for the prevention of PONV on patient outcomes and hospital resource utilization. A prospective randomized trial was conducted for patients undergoing SG. The intervention group received aprepitant and transdermal scopolamine preoperatively followed by ondansetron and dexamethasone intraoperatively, with total intravenous anesthesia. The control group received inhalational anesthetic and two intraoperative antiemetics without preoperative prophylaxis. The primary endpoint was a PONV-related delay in hospital discharge. Eighty-three patients completed the study (41 in the intervention and 42 in the control group). Eighty-nine percent of patients were discharged home on the first postoperative day. Four patients in the control group and none in the intervention group experienced a PONV-related delay in discharge (9.5% vs 0, p = 0.119). Intervention patients reported significantly lower PONV scores at all in-hospital time points examined (p = 0.0392 for verbal scores and p < 0.0001 for Rhodes Index) and significantly higher self-rated quality of recovery at 24 h (Quality of Recovery-15 instrument, p < 0.05). A multilevel approach to PONV leads to significantly lower severity of PONV and improved self-reported quality of recovery, compared with control. PONV-related readmissions, ED visits, and discharge delays were uncommon within the overall enhanced recovery cohort.
Sections du résumé
BACKGROUND
Postoperative nausea and vomiting (PONV) following sleeve gastrectomy (SG) is a common occurrence. The effect of specific interventions in PONV prevention within enhanced recovery pathways remains unclear. The aim of this study was to evaluate the impact of a comprehensive approach for the prevention of PONV on patient outcomes and hospital resource utilization.
METHODS
A prospective randomized trial was conducted for patients undergoing SG. The intervention group received aprepitant and transdermal scopolamine preoperatively followed by ondansetron and dexamethasone intraoperatively, with total intravenous anesthesia. The control group received inhalational anesthetic and two intraoperative antiemetics without preoperative prophylaxis. The primary endpoint was a PONV-related delay in hospital discharge.
RESULTS
Eighty-three patients completed the study (41 in the intervention and 42 in the control group). Eighty-nine percent of patients were discharged home on the first postoperative day. Four patients in the control group and none in the intervention group experienced a PONV-related delay in discharge (9.5% vs 0, p = 0.119). Intervention patients reported significantly lower PONV scores at all in-hospital time points examined (p = 0.0392 for verbal scores and p < 0.0001 for Rhodes Index) and significantly higher self-rated quality of recovery at 24 h (Quality of Recovery-15 instrument, p < 0.05).
CONCLUSIONS
A multilevel approach to PONV leads to significantly lower severity of PONV and improved self-reported quality of recovery, compared with control. PONV-related readmissions, ED visits, and discharge delays were uncommon within the overall enhanced recovery cohort.
Identifiants
pubmed: 32583300
doi: 10.1007/s11695-020-04795-8
pii: 10.1007/s11695-020-04795-8
doi:
Substances chimiques
Antiemetics
0
Ondansetron
4AF302ESOS
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
4250-4257Références
Ziemann-Gimmel P, Goldfarb AA, Koppman J, et al. Opioid-free total intravenous anaesthesia reduces postoperative nausea and vomiting in bariatric surgery beyond triple prophylaxis. Br J Anaesth. 2014;112(5):906–11.
pubmed: 24554545
doi: 10.1093/bja/aet551
Benevides ML, Oliveira SS, de Aguilar-Nascimento JE. The combination of haloperidol, dexamethasone, and ondansetron for prevention of postoperative nausea and vomiting in laparoscopic sleeve gastrectomy: a randomized double-blind trial. Obes Surg. 2013;23(9):1389–96.
pubmed: 23529851
doi: 10.1007/s11695-013-0923-1
Sippey M, Kasten KR, Chapman WHH, et al. 30-day readmissions after sleeve gastrectomy versus Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2016;12(5):991–6.
pubmed: 27067353
doi: 10.1016/j.soard.2016.01.036
Celio A, Bayouth L, Burruss MB, et al. Prospective assessment of postoperative nausea early after bariatric surgery. Obes Surg. 2019;29(3):858–61.
pubmed: 30565100
doi: 10.1007/s11695-018-3605-1
Bamgbade OA, Oluwole O, Khaw RR. Perioperative antiemetic therapy for fast-track laparoscopic bariatric surgery. Obes Surg. 2018;28(5):1296–301.
pubmed: 29116559
doi: 10.1007/s11695-017-3009-7
Therneau IW, Martin EE, Sprung J, et al. The role of aprepitant in prevention of postoperative nausea and vomiting after bariatric surgery. Obes Surg. 2018;28(1):37–43.
pubmed: 28674839
doi: 10.1007/s11695-017-2797-0
Sinha AC, Singh PM, Williams NW, et al. Aprepitant’s prophylactic efficacy in decreasing postoperative nausea and vomiting in morbidly obese patients undergoing bariatric surgery. Obes Surg. 2014;24(2):225–31.
pubmed: 23990451
doi: 10.1007/s11695-013-1065-1
Halliday TA, Sundqvist J, Hultin M, et al. Post-operative nausea and vomiting in bariatric surgery patients: an observational study. Acta Anaesthesiol Scand. 2017;61(5):471–9.
pubmed: 28374473
doi: 10.1111/aas.12884
Aftab H, Fagerland MW, Gondal G, et al. Pain and nausea after bariatric surgery with total intravenous anesthesia versus desflurane anesthesia: a double blind, randomized, controlled trial. Surg Obes Relat Dis. 2019;15(9):1505–12.
pubmed: 31227317
doi: 10.1016/j.soard.2019.05.010
Thorell A, MacCormick AD, Awad S, et al. Guidelines for perioperative care in bariatric surgery: enhanced recovery after surgery (ERAS) society recommendations. World J Surg. 2016;40(9):2065–83.
pubmed: 26943657
doi: 10.1007/s00268-016-3492-3
Memtsoudis SG, Poeran J, Kehlet H. Enhanced recovery after surgery in the United States: from evidence-based practice to uncertain science? JAMA. 2019;321(11):1049–50.
pubmed: 30816910
doi: 10.1001/jama.2019.1070
Rhodes VA, McDaniel RW. The index of nausea, vomiting, and retching: a new format of the index of nausea and vomiting. Oncol Nurs Forum. 1999;26(5):889–94.
pubmed: 10382187
Afaneh C, Costa R, Pomp A, et al. A prospective randomized controlled trial assessing the efficacy of omentopexy during laparoscopic sleeve gastrectomy in reducing postoperative gastrointestinal symptoms. Surg Endosc. 2015;29(1):41–7.
pubmed: 24962864
doi: 10.1007/s00464-014-3651-2
Stark PA, Myles PS, Burke JA. Development and psychometric evaluation of a postoperative quality of recovery score: the QoR-15. Anesthesiology. 2013;118(6):1332–40.
pubmed: 23411725
doi: 10.1097/ALN.0b013e318289b84b
Ignat M, Vix M, Imad I, et al. Randomized trial of Roux-en-Y gastric bypass versus sleeve gastrectomy in achieving excess weight loss. Br J Surg. 2017;104(3):248–56.
pubmed: 27901287
doi: 10.1002/bjs.10400
Nickel F, Schmidt L, Bruckner T, et al. Gastrointestinal quality of life improves significantly after sleeve gastrectomy and Roux-en-Y gastric bypass-a prospective cross-sectional study within a 2-year follow-up. Obes Surg. 2017;27(5):1292–7.
pubmed: 27878423
doi: 10.1007/s11695-016-2464-x
Tarride JE, Breau R, Sharma AM, et al. The effect of bariatric surgery on mobility, health-related quality of life, healthcare resource utilization, and employment status. Obes Surg. 2017;27(2):349–56.
pubmed: 27503212
doi: 10.1007/s11695-016-2298-6
Sauerland S, Weiner S, Dolezalova K, et al. Mapping utility scores from a disease-specific quality-of-life measure in bariatric surgery patients. Value Health. 2009;12(2):364–70.
pubmed: 20667063
doi: 10.1111/j.1524-4733.2008.00442.x
Date RS, Walton SJ, Ryan N, et al. Is selection bias toward super obese patients in the rationing of metabolic surgery justified?--a pilot study from the United Kingdom. Surg Obes Relat Dis. 2013;9(6):981–6.
pubmed: 23561962
doi: 10.1016/j.soard.2013.01.022
Urbaniak GC, Plous S. Research randomizer (version 4.0) [computer software]. 2013 Retrieved on June 22, 2017, from http://www.randomizer.org/
Pan PH, Lee SC, Harris LC. Antiemetic prophylaxis for postdischarge nausea and vomiting and impact on functional quality of living during recovery in patients with high emetic risks: a prospective, randomized, double-blind comparison of two prophylactic antiemetic regimens. Anesth Analg. 2008;107(2):429–38.
pubmed: 18633020
doi: 10.1213/ane.0b013e318172f992
Urbach DR, Harnish JL, McIlroy JH, et al. A measure of quality of life after abdominal surgery. Qual Life Res. 2006;15(6):1053–61.
pubmed: 16900285
doi: 10.1007/s11136-006-0047-3